» Articles » PMID: 22888312

Novel Insights into the Distribution and Functional Aspects of the Calcium Binding Protein Secretagogin from Studies on Rat Brain and Primary Neuronal Cell Culture

Overview
Specialty Molecular Biology
Date 2012 Aug 14
PMID 22888312
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Secretagogin is a calcium binding protein (CBP) highly expressed in neuroendocrine cells. It has been shown to be involved in insulin secretion from pancreatic beta cells and is a strong candidate as a biomarker for endocrine tumors, stroke, and eventually psychiatric conditions. Secretagogin has been hypothesized to exert a neuroprotective role in neurodegenerative diseases like Alzheimer's disease. The expression pattern of Secretagogin is not conserved from rodents to humans. We used brain tissue and primary neuronal cell cultures from rat to further characterize this CBP in rodents and to perform a few functional assays in vitro. Immunohistochemistry on rat brain slices revealed a high density of Secretagogin-positive cells in distinct brain regions. Secretagogin was found in the cytosol or associated with subcellular compartments. We tested primary neuronal cultures for their suitability as model systems to further investigate functional properties of Secretagogin. These cultures can easily be manipulated by treatment with drugs or by transfection with test constructs interfering with signaling cascades that might be linked to the cellular function of Secretagogin. We show that, like in pancreatic beta cells and insulinoma cell lines, also in neurons the expression level of Secretagogin is dependent on extracellular insulin and glucose. Further, we show also for rat brain neuronal tissue that Secretagogin interacts with the microtubule-associated protein Tau and that this interaction is dependent on Ca(2+). Future studies should aim to study in further detail the molecular properties and function of Secretagogin in individual neuronal cell types, in particular the subcellular localization and trafficking of this protein and a possible active secretion by neurons.

Citing Articles

Secretagogin regulates asynchronous and spontaneous glutamate release in hippocampal neurons through interaction with Doc2α.

Tu Y, Qin J, Zhang Q, Tang T, Wang L, Yao J Life Med. 2025; 2(5):lnad041.

PMID: 39872889 PMC: 11749858. DOI: 10.1093/lifemedi/lnad041.


Immunohistochemical distribution of secretagogin in the mouse brain.

Tellez de Meneses P, Perez-Revuelta L, Canal-Alonso A, Hernandez-Perez C, Cocho T, Valero J Front Neuroanat. 2023; 17:1224342.

PMID: 37711587 PMC: 10498459. DOI: 10.3389/fnana.2023.1224342.


SCGN deficiency is a risk factor for autism spectrum disorder.

Liu Z, Tan S, Zhou L, Chen L, Liu M, Wang W Signal Transduct Target Ther. 2023; 8(1):3.

PMID: 36588101 PMC: 9806109. DOI: 10.1038/s41392-022-01225-2.


Rabies virus infection is associated with alterations in the expression of parvalbumin and secretagogin in mice brain.

Kanu B, Kia G, Aimola I, Korie G, Tekki I Metab Brain Dis. 2021; 36(6):1267-1275.

PMID: 33783673 PMC: 8008021. DOI: 10.1007/s11011-021-00717-4.


Postnatal Developmental Expression Profile Classifies the Indusium Griseum as a Distinct Subfield of the Hippocampal Formation.

Sanders M, Petrasch-Parwez E, Habbes H, During M, Forster E Front Cell Dev Biol. 2021; 8:615571.

PMID: 33511122 PMC: 7835525. DOI: 10.3389/fcell.2020.615571.


References
1.
Yu J, Chang R, Tan L . Calcium dysregulation in Alzheimer's disease: from mechanisms to therapeutic opportunities. Prog Neurobiol. 2009; 89(3):240-55. DOI: 10.1016/j.pneurobio.2009.07.009. View

2.
Demuro A, Parker I, Stutzmann G . Calcium signaling and amyloid toxicity in Alzheimer disease. J Biol Chem. 2010; 285(17):12463-8. PMC: 2857063. DOI: 10.1074/jbc.R109.080895. View

3.
Burgoyne R, Haynes L . Understanding the physiological roles of the neuronal calcium sensor proteins. Mol Brain. 2012; 5(1):2. PMC: 3271974. DOI: 10.1186/1756-6606-5-2. View

4.
Braunewell K . The darker side of Ca2+ signaling by neuronal Ca2+-sensor proteins: from Alzheimer's disease to cancer. Trends Pharmacol Sci. 2005; 26(7):345-51. DOI: 10.1016/j.tips.2005.04.008. View

5.
Camandola S, Mattson M . Aberrant subcellular neuronal calcium regulation in aging and Alzheimer's disease. Biochim Biophys Acta. 2010; 1813(5):965-73. PMC: 3032815. DOI: 10.1016/j.bbamcr.2010.10.005. View